Literature DB >> 33482322

Postoperative Outcomes after Index vs Interval Cholecystectomy for Perforated Cholecystitis.

Laura K Krecko1, Tatiana Hoyos Gomez1, John E Scarborough1, Hee Soo Jung2.   

Abstract

BACKGROUND: Gallbladder perforation is a known morbid sequela of acute cholecystitis, yet evidence for its optimal management remains conflicting. This study compares outcomes in patients with perforated cholecystitis who underwent cholecystectomy at the time of index hospital admission with those in patients who underwent interval cholecystectomy. STUDY
DESIGN: A retrospective analysis was conducted of 654 patients from the American College of Surgeons NSQIP database who underwent cholecystectomy for perforated cholecystitis (2006-2018). Primary outcomes were 30-day postoperative major and minor morbidity, 30-day mortality, and need for prolonged hospitalization. Patient and procedure characteristics and outcomes were compared using Mann-Whitney rank sum test for continuous variables and Pearson chi-square tests for categorical variables. A subset analysis was conducted of patients matched on propensity for undergoing interval cholecystectomy.
RESULTS: The 30-day postoperative mortality rate of matched cohort patients undergoing index cholecystectomy was 7% vs 0% of patients undergoing interval cholecystectomy (p = 0.01). The 30-day minor morbidity rates were 2% for index and 8% for interval patients (p = 0.06), and the major morbidity rates were 33% for index and 14% for interval patients (p = 0.003). Of the index patients, 27% required prolonged hospitalization compared with 6% of interval patients (p < 0.001). Results showed similar trends in the unmatched analysis.
CONCLUSIONS: Patients who underwent index cholecystectomy had significantly longer postoperative hospitalizations and higher 30-day postoperative major morbidity and mortality. There were no differences in 30-day minor morbidity. Selected patients with perforated cholecystitis can benefit from operative management on an interval, rather than urgent, basis.
Copyright © 2021 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33482322      PMCID: PMC8021230          DOI: 10.1016/j.jamcollsurg.2020.11.034

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.532


  12 in total

1.  Can early laparoscopic cholecystectomy be the optimal management of cholecystitis with gallbladder perforation? A single institute experience of 74 cases.

Authors:  Hung-Chieh Lo; Yu-Chun Wang; Li-Ting Su; Chi-Hsun Hsieh
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

2.  Gallbladder perforation: risk factors and outcome.

Authors:  Dimitrios Stefanidis; Kenneth R Sirinek; Juliane Bingener
Journal:  J Surg Res       Date:  2006-01-18       Impact factor: 2.192

3.  Risk factors for prolonged length of stay after major elective surgery.

Authors:  T C Collins; J Daley; W H Henderson; S F Khuri
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

4.  Gallbladder perforation: morbidity, mortality and preoperative risk prediction.

Authors:  F Ausania; S Guzman Suarez; H Alvarez Garcia; P Senra del Rio; E Casal Nuñez
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

5.  Outcome of acute perforated cholecystitis: a register study of over 5000 cases from a quality control database in Germany.

Authors:  Stefan Jansen; Johannes Doerner; Susanne Macher-Heidrich; Hubert Zirngibl; Peter C Ambe
Journal:  Surg Endosc       Date:  2016-08-23       Impact factor: 4.584

6.  Percutaneous drainage versus emergency cholecystectomy for the treatment of acute cholecystitis in critically ill patients: does it matter?

Authors:  E Melloul; A Denys; N Demartines; J-M Calmes; M Schäfer
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

Review 7.  Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis.

Authors:  Kohji Okamoto; Kenji Suzuki; Tadahiro Takada; Steven M Strasberg; Horacio J Asbun; Itaru Endo; Yukio Iwashita; Taizo Hibi; Henry A Pitt; Akiko Umezawa; Koji Asai; Ho-Seong Han; Tsann-Long Hwang; Yasuhisa Mori; Yoo-Seok Yoon; Wayne Shih-Wei Huang; Giulio Belli; Christos Dervenis; Masamichi Yokoe; Seiki Kiriyama; Takao Itoi; Palepu Jagannath; O James Garden; Fumihiko Miura; Masafumi Nakamura; Akihiko Horiguchi; Go Wakabayashi; Daniel Cherqui; Eduardo de Santibañes; Satoru Shikata; Yoshinori Noguchi; Tomohiko Ukai; Ryota Higuchi; Keita Wada; Goro Honda; Avinash Nivritti Supe; Masahiro Yoshida; Toshihiko Mayumi; Dirk J Gouma; Daniel J Deziel; Kui-Hin Liau; Miin-Fu Chen; Kazunori Shibao; Keng-Hao Liu; Cheng-Hsi Su; Angus C W Chan; Dong-Sup Yoon; In-Seok Choi; Eduard Jonas; Xiao-Ping Chen; Sheung Tat Fan; Chen-Guo Ker; Mariano Eduardo Giménez; Seigo Kitano; Masafumi Inomata; Koichi Hirata; Kazuo Inui; Yoshinobu Sumiyama; Masakazu Yamamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2017-12-20       Impact factor: 7.027

8.  Percutaneous transhepatic gall bladder drainage: a better initial therapeutic choice for patients with gall bladder perforation in the emergency department.

Authors:  C-C Huang; H-C Lo; Y-M Tzeng; H-H Huang; J-D Chen; W-F Kao; D H-T Yen; C-I Huang; C-H Lee
Journal:  Emerg Med J       Date:  2007-12       Impact factor: 2.740

9.  TG13 flowchart for the management of acute cholangitis and cholecystitis.

Authors:  Fumihiko Miura; Tadahiro Takada; Steven M Strasberg; Joseph S Solomkin; Henry A Pitt; Dirk J Gouma; O James Garden; Markus W Büchler; Masahiro Yoshida; Toshihiko Mayumi; Kohji Okamoto; Harumi Gomi; Shinya Kusachi; Seiki Kiriyama; Masamichi Yokoe; Yasutoshi Kimura; Ryota Higuchi; Yuichi Yamashita; John A Windsor; Toshio Tsuyuguchi; Toshifumi Gabata; Takao Itoi; Jiro Hata; Kui-Hin Liau
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-01       Impact factor: 7.027

10.  Advanced gallbladder inflammation is a risk factor for gallbladder perforation in patients with acute cholecystitis.

Authors:  Stefan Jansen; Maciej Stodolski; Hubert Zirngibl; Daniel Gödde; Peter C Ambe
Journal:  World J Emerg Surg       Date:  2018-02-20       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.